Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Miyajima

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Microbiology and Immunology|May 8, 1998
Liver-associated natural killer activity in cirrhotic ratsM Shirachi, M Sata, I Miyajima, et al.
Geka Chiryo. Surgical Therapy|April 1, 1972
[Clinical use of a new muscle relaxant, pancuronium bromide]T Muteki, K Motomatsu, I Miyajima, et al.
Nucleic Acids Research|August 24, 1984
Analysis of full-length cDNA clones carrying GAL1 of Saccharomyces cerevisiae: a model system for cDNA expressionA Miyajima, N Nakayama, I Miyajima, et al.
Genetics|August 1, 1988
Suppressors of a gpa1 mutation cause sterility in Saccharomyces cerevisiaeI Miyajima, N Nakayama, M Nakafuku, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|July 1, 1996
Sequential interferon-alpha and beta treatment in patients with chronic hepatitis CI Miyajima, M Sata, Y Uchimura, et al.
Scandinavian Journal of Infectious Diseases|June 25, 1999
Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosisS Murashima, T Ide, I Miyajima, et al.
Oncology Reports|April 4, 1998
The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatmentI Miyajima, M Sata, R Kumashiro, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1996
Evaluation of interferon treatment in cirrhotic patients with hepatitis CT Ide, M Sata, H Suzuki, et al.
The Journal of Biological Chemistry|July 25, 1993
Ligand-dependent activation of chimeric receptors with the cytoplasmic domain of the interleukin-3 receptor beta subunit (beta IL3)K Sakamaki, H M Wang, I Miyajima, et al.
The Journal of Clinical Investigation|March 1, 1997
Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chainsD Dombrowicz, V Flamand, I Miyajima, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Microbiology and Immunology|May 8, 1998
Liver-associated natural killer activity in cirrhotic ratsM Shirachi, M Sata, I Miyajima, et al.
Geka Chiryo. Surgical Therapy|April 1, 1972
[Clinical use of a new muscle relaxant, pancuronium bromide]T Muteki, K Motomatsu, I Miyajima, et al.
Nucleic Acids Research|August 24, 1984
Analysis of full-length cDNA clones carrying GAL1 of Saccharomyces cerevisiae: a model system for cDNA expressionA Miyajima, N Nakayama, I Miyajima, et al.
Genetics|August 1, 1988
Suppressors of a gpa1 mutation cause sterility in Saccharomyces cerevisiaeI Miyajima, N Nakayama, M Nakafuku, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|July 1, 1996
Sequential interferon-alpha and beta treatment in patients with chronic hepatitis CI Miyajima, M Sata, Y Uchimura, et al.
Scandinavian Journal of Infectious Diseases|June 25, 1999
Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosisS Murashima, T Ide, I Miyajima, et al.
Oncology Reports|April 4, 1998
The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatmentI Miyajima, M Sata, R Kumashiro, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1996
Evaluation of interferon treatment in cirrhotic patients with hepatitis CT Ide, M Sata, H Suzuki, et al.
The Journal of Biological Chemistry|July 25, 1993
Ligand-dependent activation of chimeric receptors with the cytoplasmic domain of the interleukin-3 receptor beta subunit (beta IL3)K Sakamaki, H M Wang, I Miyajima, et al.
The Journal of Clinical Investigation|March 1, 1997
Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chainsD Dombrowicz, V Flamand, I Miyajima, et al.
Pageof 3